Related Experiment Video
Updated: Aug 24, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Anemia after kidney transplantation.
Isabella Guzzo1, Meredith A Atkinson2
1Division of Nephrology and Dialysis, Department of Pediatrics, Bambino Gesù Children's Hospital and Research Institute, Piazza Sant'Onofrio 4, 00165, Rome, Italy.
Post-transplantation anemia (PTA) affects many pediatric kidney transplant recipients. Early evaluation and treatment targeting causes like iron deficiency are crucial for better outcomes.
Area of Science:
- Nephrology
- Pediatric Transplantation
- Hematology
Background:
- Anemia is a common complication in pediatric kidney transplant recipients (KTR), with prevalence ranging from 20-80%.
- Causes are multifactorial, including iron deficiency (early PTA) and impaired glomerular filtration rate (GFR) (late PTA).
- Post-transplantation anemia (PTA) is linked to adverse outcomes like allograft dysfunction, cardiovascular issues, and mortality.
Purpose of the Study:
- To highlight the significance of anemia evaluation in pediatric KTR.
- To emphasize early detection and management of PTA to improve prognosis.
- To discuss the causes, risk factors, and treatment strategies for PTA.
Main Methods:
- Review of factors contributing to anemia in pediatric KTR.
- Discussion of recommended diagnostic evaluations around 3 months post-transplantation.
- Evaluation of treatment options, including iron supplementation and erythropoietin therapy.
Main Results:
- Iron deficiency is the primary cause of early PTA, while impaired GFR often causes late PTA.
- Medications, viral infections, inflammation, and comorbidities also contribute to PTA.
- Anemia evaluation should include iron status, vitamin B12, folate, hemolysis markers, and viral PCR.
Conclusions:
- Anemia evaluation approximately 3 months post-transplantation is recommended for early treatment and improved prognosis.
- Treatment should address underlying causes, with iron supplementation and erythropoietin therapy as potential options.
- Optimizing anemia status before transplantation is vital to reduce perioperative transfusion needs and avoid allosensitization.
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care

